• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Regentis Biomaterials Ltd. Ordinary Shares (NY:RGNT)

7.050 +0.140 (+2.03%)
Streaming Delayed Price Updated: 9:30 AM EST, Jan 9, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 540
Open 7.050
Bid (Size) 6.410 (200)
Ask (Size) 7.000 (100)
Prev. Close 6.910
Today's Range 7.050 - 7.050
52wk Range 5.750 - 7.698
Shares Outstanding 24,114,610
Dividend Yield N/A
Chart for  (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
News headline image
Regentis' GelrinC Establishes Long-Term Durability of Cartilage Repair Through Quantitative MOCART Evaluation
January 06, 2026
Via ACCESS Newswire
InvestorNewsBreaks – Regentis Biomaterials Ltd. (NYSE American: RGNT) Secures New U.S. Patent for GelrinC Liquid Formulation
January 05, 2026
Via Investor Brand Network
Topics Intellectual Property

Performance

YTD
+3.5%
+3.5%
1 Month
-6.0%
-6.0%
3 Month
-6.0%
-6.0%
6 Month
-6.0%
-6.0%
1 Year
-6.0%
-6.0%

More News

Read More
News headline image
Regentis Biomaterials Granted New U.S. Patent for its Off-the-Shelf Regenerative Cartilage Repair Product GelrinC
December 18, 2025
Via ACCESS Newswire
News headline image
Regentis Biomaterials Commences Trading on NYSE: Set to Transform Cartilage Repair Market with Off-the-Shelf Regenerative Product
December 08, 2025
Via ACCESS Newswire
News headline image
Regentis Biomaterials Ltd. Announces Closing of Initial Public Offering
December 05, 2025
From Regentis Biomaterials Ltd.
Via GlobeNewswire

Frequently Asked Questions

Is Regentis Biomaterials Ltd. Ordinary Shares publicly traded?
Yes, Regentis Biomaterials Ltd. Ordinary Shares is publicly traded.
What exchange does Regentis Biomaterials Ltd. Ordinary Shares trade on?
Regentis Biomaterials Ltd. Ordinary Shares trades on the New York Stock Exchange
What is the ticker symbol for Regentis Biomaterials Ltd. Ordinary Shares?
The ticker symbol for Regentis Biomaterials Ltd. Ordinary Shares is RGNT on the New York Stock Exchange
What is the current price of Regentis Biomaterials Ltd. Ordinary Shares?
The current price of Regentis Biomaterials Ltd. Ordinary Shares is 7.050
When was Regentis Biomaterials Ltd. Ordinary Shares last traded?
The last trade of Regentis Biomaterials Ltd. Ordinary Shares was at 01/09/26 09:30 AM ET
What is the market capitalization of Regentis Biomaterials Ltd. Ordinary Shares?
The market capitalization of Regentis Biomaterials Ltd. Ordinary Shares is 170.01M
How many shares of Regentis Biomaterials Ltd. Ordinary Shares are outstanding?
Regentis Biomaterials Ltd. Ordinary Shares has 170M shares outstanding.
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap